Antioxidant activity of xymedone in rats with chronic autoimmune inflammation by Valeeva I. et al.
Eksperimental'naya i Klinicheskaya Farmakologiya 2016 vol.79 N1, pages 33-37
Antioxidant activity of xymedone in rats with chronic
autoimmune inflammation
Valeeva I., Titarenko A., Khaziakhmetova V., Ziganshina L.
Kazan Federal University, 420008, Kremlevskaya 18, Kazan, Russia
Abstract
© Folium Publishing House 2016.Effects of drug xymedone (in comparison to ionol) in a group of
32  white  rats  with  experimental  model  of  chronic  autoimmune  inflammation  of  rat  paws
(induced by Freund's adjuvant) were studied by measuring the volume of paw edema and
determining the levels  of  lipid  peroxidation (LPO)  products  and the activity  of  antioxidant
enzymes in various tissues. Chronic autoimmune inflammation induced by Freund's adjuvant
was  characterized  by  the  LPO intensification  and  disturbances  of  the  level  of  antioxidant
enzymes.  Intragastric  administration  of  xymedone  (2  2-dihydro-4  6-dimethyl-N-(β-oxy-et-
yl)-2-pyrimidon)  at  a  dose  of  169  mg/kg  and  reference  drug  ionol  (2  6-ditretbutyl-
4-methylphenol) at a dose of 220 mg/kg increased the activity of serum antioxidant enzymes by
19% and 11% respectively decreased the serum level of  nitrite ion by 62% and 50% and
reduced the levels of LPO products in rat blood and homogenates of liver kidney and spleen by
up to 80% (p < 0.05).
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